
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk
Iris E. Jansen, Jeanne E. Savage, Kyoko Watanabe, et al.
Nature Genetics (2019) Vol. 51, Iss. 3, pp. 404-413
Open Access | Times Cited: 2068
Iris E. Jansen, Jeanne E. Savage, Kyoko Watanabe, et al.
Nature Genetics (2019) Vol. 51, Iss. 3, pp. 404-413
Open Access | Times Cited: 2068
Showing 1-25 of 2068 citing articles:
Alzheimer's disease
Philip Scheltens, Bart De Strooper, Miia Kivipelto, et al.
The Lancet (2021) Vol. 397, Iss. 10284, pp. 1577-1590
Open Access | Times Cited: 3125
Philip Scheltens, Bart De Strooper, Miia Kivipelto, et al.
The Lancet (2021) Vol. 397, Iss. 10284, pp. 1577-1590
Open Access | Times Cited: 3125
The neuropathological diagnosis of Alzheimer’s disease
Michael DeTure, Dennis W. Dickson
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 2437
Michael DeTure, Dennis W. Dickson
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 2437
Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies
Mike A. Nalls, Cornelis Blauwendraat, Costanza L. Vallerga, et al.
The Lancet Neurology (2019) Vol. 18, Iss. 12, pp. 1091-1102
Open Access | Times Cited: 1987
Mike A. Nalls, Cornelis Blauwendraat, Costanza L. Vallerga, et al.
The Lancet Neurology (2019) Vol. 18, Iss. 12, pp. 1091-1102
Open Access | Times Cited: 1987
New insights into the genetic etiology of Alzheimer’s disease and related dementias
Céline Bellenguez, Fahri Küçükali, Iris E. Jansen, et al.
Nature Genetics (2022) Vol. 54, Iss. 4, pp. 412-436
Open Access | Times Cited: 1519
Céline Bellenguez, Fahri Küçükali, Iris E. Jansen, et al.
Nature Genetics (2022) Vol. 54, Iss. 4, pp. 412-436
Open Access | Times Cited: 1519
The Amyloid-β Pathway in Alzheimer’s Disease
Harald Hampel, John Hardy, Kaj Blennow, et al.
Molecular Psychiatry (2021) Vol. 26, Iss. 10, pp. 5481-5503
Open Access | Times Cited: 1072
Harald Hampel, John Hardy, Kaj Blennow, et al.
Molecular Psychiatry (2021) Vol. 26, Iss. 10, pp. 5481-5503
Open Access | Times Cited: 1072
The genetic architecture of Parkinson's disease
Cornelis Blauwendraat, Mike A. Nalls, Andrew Singleton
The Lancet Neurology (2019) Vol. 19, Iss. 2, pp. 170-178
Open Access | Times Cited: 888
Cornelis Blauwendraat, Mike A. Nalls, Andrew Singleton
The Lancet Neurology (2019) Vol. 19, Iss. 2, pp. 170-178
Open Access | Times Cited: 888
A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer’s disease
Douglas P. Wightman, Iris E. Jansen, Jeanne E. Savage, et al.
Nature Genetics (2021) Vol. 53, Iss. 9, pp. 1276-1282
Open Access | Times Cited: 724
Douglas P. Wightman, Iris E. Jansen, Jeanne E. Savage, et al.
Nature Genetics (2021) Vol. 53, Iss. 9, pp. 1276-1282
Open Access | Times Cited: 724
The genetic architecture of the human cerebral cortex
Katrina L. Grasby, Neda Jahanshad, Jodie N. Painter, et al.
Science (2020) Vol. 367, Iss. 6484
Open Access | Times Cited: 723
Katrina L. Grasby, Neda Jahanshad, Jodie N. Painter, et al.
Science (2020) Vol. 367, Iss. 6484
Open Access | Times Cited: 723
Spatial Transcriptomics and In Situ Sequencing to Study Alzheimer’s Disease
Wei-Ting Chen, Ashley Lu, Katleen Craessaerts, et al.
Cell (2020) Vol. 182, Iss. 4, pp. 976-991.e19
Open Access | Times Cited: 717
Wei-Ting Chen, Ashley Lu, Katleen Craessaerts, et al.
Cell (2020) Vol. 182, Iss. 4, pp. 976-991.e19
Open Access | Times Cited: 717
Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group
Bruno Dubois, Nicolas Villain, Giovanni B. Frisoni, et al.
The Lancet Neurology (2021) Vol. 20, Iss. 6, pp. 484-496
Open Access | Times Cited: 707
Bruno Dubois, Nicolas Villain, Giovanni B. Frisoni, et al.
The Lancet Neurology (2021) Vol. 20, Iss. 6, pp. 484-496
Open Access | Times Cited: 707
Brain cell type–specific enhancer–promoter interactome maps and disease - risk association
Alexi Nott, Inge R. Holtman, Nicole G. Coufal, et al.
Science (2019) Vol. 366, Iss. 6469, pp. 1134-1139
Open Access | Times Cited: 613
Alexi Nott, Inge R. Holtman, Nicole G. Coufal, et al.
Science (2019) Vol. 366, Iss. 6469, pp. 1134-1139
Open Access | Times Cited: 613
A human brain vascular atlas reveals diverse mediators of Alzheimer’s risk
Andrew C. Yang, Ryan T. Vest, Fabian Kern, et al.
Nature (2022) Vol. 603, Iss. 7903, pp. 885-892
Open Access | Times Cited: 537
Andrew C. Yang, Ryan T. Vest, Fabian Kern, et al.
Nature (2022) Vol. 603, Iss. 7903, pp. 885-892
Open Access | Times Cited: 537
Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer’s disease
Marta Olah, Vilas Menon, Naomi Habib, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 534
Marta Olah, Vilas Menon, Naomi Habib, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 534
Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases
Yiheng Chen, Tianyuan Lu, U. Pettersson, et al.
Nature Genetics (2023) Vol. 55, Iss. 1, pp. 44-53
Open Access | Times Cited: 483
Yiheng Chen, Tianyuan Lu, U. Pettersson, et al.
Nature Genetics (2023) Vol. 55, Iss. 1, pp. 44-53
Open Access | Times Cited: 483
Single-nucleus chromatin accessibility and transcriptomic characterization of Alzheimer’s disease
Samuel Morabito, Emily Miyoshi, Neethu Michael, et al.
Nature Genetics (2021) Vol. 53, Iss. 8, pp. 1143-1155
Open Access | Times Cited: 460
Samuel Morabito, Emily Miyoshi, Neethu Michael, et al.
Nature Genetics (2021) Vol. 53, Iss. 8, pp. 1143-1155
Open Access | Times Cited: 460
Amyloid-β-independent regulators of tau pathology in Alzheimer disease
Rik van der Kant, Lawrence S.B. Goldstein, Rik Ossenkoppele
Nature reviews. Neuroscience (2019) Vol. 21, Iss. 1, pp. 21-35
Closed Access | Times Cited: 451
Rik van der Kant, Lawrence S.B. Goldstein, Rik Ossenkoppele
Nature reviews. Neuroscience (2019) Vol. 21, Iss. 1, pp. 21-35
Closed Access | Times Cited: 451
Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer’s disease risk genes
Jeremy Schwartzentruber, Sarah Cooper, Jimmy Z. Liu, et al.
Nature Genetics (2021) Vol. 53, Iss. 3, pp. 392-402
Open Access | Times Cited: 410
Jeremy Schwartzentruber, Sarah Cooper, Jimmy Z. Liu, et al.
Nature Genetics (2021) Vol. 53, Iss. 3, pp. 392-402
Open Access | Times Cited: 410
The multiplex model of the genetics of Alzheimer’s disease
Rebecca Sims, Matthew Hill, Julie Williams
Nature Neuroscience (2020) Vol. 23, Iss. 3, pp. 311-322
Open Access | Times Cited: 401
Rebecca Sims, Matthew Hill, Julie Williams
Nature Neuroscience (2020) Vol. 23, Iss. 3, pp. 311-322
Open Access | Times Cited: 401
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology
Wouter van Rheenen, Rick A. A. van der Spek, Mark K. Bakker, et al.
Nature Genetics (2021) Vol. 53, Iss. 12, pp. 1636-1648
Open Access | Times Cited: 392
Wouter van Rheenen, Rick A. A. van der Spek, Mark K. Bakker, et al.
Nature Genetics (2021) Vol. 53, Iss. 12, pp. 1636-1648
Open Access | Times Cited: 392
Cross-Species Single-Cell Analysis Reveals Divergence of the Primate Microglia Program
Laufey Geirsdóttir, Eyal David, Hadas Keren‐Shaul, et al.
Cell (2019) Vol. 179, Iss. 7, pp. 1609-1622.e16
Open Access | Times Cited: 390
Laufey Geirsdóttir, Eyal David, Hadas Keren‐Shaul, et al.
Cell (2019) Vol. 179, Iss. 7, pp. 1609-1622.e16
Open Access | Times Cited: 390
Mapping the proteo-genomic convergence of human diseases
Maik Pietzner, Eleanor Wheeler, Julia Carrasco-Zanini, et al.
Science (2021) Vol. 374, Iss. 6569
Open Access | Times Cited: 377
Maik Pietzner, Eleanor Wheeler, Julia Carrasco-Zanini, et al.
Science (2021) Vol. 374, Iss. 6569
Open Access | Times Cited: 377
Genetic drug target validation using Mendelian randomisation
Amand F. Schmidt, Chris Finan, María Gordillo‐Marañón, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 360
Amand F. Schmidt, Chris Finan, María Gordillo‐Marañón, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 360
The probabilistic model of Alzheimer disease: the amyloid hypothesis revised
Giovanni B. Frisoni, Daniele Altomare, Dietmar Rudolf Thal, et al.
Nature reviews. Neuroscience (2021) Vol. 23, Iss. 1, pp. 53-66
Open Access | Times Cited: 343
Giovanni B. Frisoni, Daniele Altomare, Dietmar Rudolf Thal, et al.
Nature reviews. Neuroscience (2021) Vol. 23, Iss. 1, pp. 53-66
Open Access | Times Cited: 343
Genome-wide meta-analysis of problematic alcohol use in 435,563 individuals yields insights into biology and relationships with other traits
Hang Zhou, Julia Sealock, Sandra Sanchez‐Roige, et al.
Nature Neuroscience (2020) Vol. 23, Iss. 7, pp. 809-818
Open Access | Times Cited: 342
Hang Zhou, Julia Sealock, Sandra Sanchez‐Roige, et al.
Nature Neuroscience (2020) Vol. 23, Iss. 7, pp. 809-818
Open Access | Times Cited: 342
Siglecs as Immune Cell Checkpoints in Disease
Shiteng Duan, James C. Paulson
Annual Review of Immunology (2020) Vol. 38, Iss. 1, pp. 365-395
Open Access | Times Cited: 339
Shiteng Duan, James C. Paulson
Annual Review of Immunology (2020) Vol. 38, Iss. 1, pp. 365-395
Open Access | Times Cited: 339